ATE405249T1 - BODY ODOR-CHANGING BIOLOGICALLY ACTIVE SUBSTANCES - Google Patents

BODY ODOR-CHANGING BIOLOGICALLY ACTIVE SUBSTANCES

Info

Publication number
ATE405249T1
ATE405249T1 AT03725098T AT03725098T ATE405249T1 AT E405249 T1 ATE405249 T1 AT E405249T1 AT 03725098 T AT03725098 T AT 03725098T AT 03725098 T AT03725098 T AT 03725098T AT E405249 T1 ATE405249 T1 AT E405249T1
Authority
AT
Austria
Prior art keywords
changing
biologically active
active substances
body odor
mhc
Prior art date
Application number
AT03725098T
Other languages
German (de)
Inventor
Thomas Boehm
Manfred Milinski
Original Assignee
Max Planck Gesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Planck Gesellschaft filed Critical Max Planck Gesellschaft
Application granted granted Critical
Publication of ATE405249T1 publication Critical patent/ATE405249T1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q13/00—Formulations or additives for perfume preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Birds (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Saccharide Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The invention relates to the use of MHC ligands, e.g. MHC-binding peptides, for the manufacture of an agent for modifying bodily odours. Particularly, the invention is applicable in the field of cosmetics and medicine.
AT03725098T 2002-04-26 2003-04-25 BODY ODOR-CHANGING BIOLOGICALLY ACTIVE SUBSTANCES ATE405249T1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02009588A EP1358869A1 (en) 2002-04-26 2002-04-26 Biologically active compounds for the modificaton of bodily odours

Publications (1)

Publication Number Publication Date
ATE405249T1 true ATE405249T1 (en) 2008-09-15

Family

ID=28799644

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03725098T ATE405249T1 (en) 2002-04-26 2003-04-25 BODY ODOR-CHANGING BIOLOGICALLY ACTIVE SUBSTANCES

Country Status (9)

Country Link
US (1) US20060039883A1 (en)
EP (2) EP1358869A1 (en)
JP (1) JP2005532299A (en)
AT (1) ATE405249T1 (en)
AU (1) AU2003227677A1 (en)
CA (1) CA2483750C (en)
DE (1) DE60323082D1 (en)
ES (1) ES2312774T3 (en)
WO (1) WO2003090705A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7592910B2 (en) * 2005-09-28 2009-09-22 Social Fabric Corporation Matching system
EP2072529A1 (en) * 2007-12-21 2009-06-24 basisnote AG MHC rapid assay used for the customization of odours
US20120315221A1 (en) * 2011-06-13 2012-12-13 Tuck Edward F Human sample matching system

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3929675A (en) * 1967-05-15 1975-12-30 Int Flavors & Fragrances Inc Novel products and processes
KR0148491B1 (en) * 1991-05-30 1998-11-02 강진구 Deodorants
AU2361595A (en) * 1994-04-22 1995-11-16 Sloan-Kettering Institute For Cancer Research Induction of cytotoxic t lymphocytes (ctl) using antigenic peptides and a suitable adjuvant
CA2263871A1 (en) * 1996-08-23 1998-02-26 Massachusetts Institute Of Technology Allogeneic histocompatibility complexes as mediators of cell destruction
DE10021579B4 (en) * 2000-04-27 2011-07-07 Coty B.V. Fragrance composition of HLA molecules

Also Published As

Publication number Publication date
WO2003090705A1 (en) 2003-11-06
EP1499284A1 (en) 2005-01-26
AU2003227677A1 (en) 2003-11-10
DE60323082D1 (en) 2008-10-02
EP1358869A1 (en) 2003-11-05
CA2483750A1 (en) 2003-11-06
CA2483750C (en) 2011-11-01
EP1499284B1 (en) 2008-08-20
JP2005532299A (en) 2005-10-27
ES2312774T3 (en) 2009-03-01
US20060039883A1 (en) 2006-02-23

Similar Documents

Publication Publication Date Title
CO5611160A2 (en) CONJUGATES OF THERAPEUTIC OR CYTOTOXIC AGENTS AND BIOLOGICALLY ACTIVE PEPTIDES
DE60032486D1 (en) PRION PROTEIN PEPTIDES AND ITS USE
ATE504308T1 (en) ANTIMICROBIAL CATIONIC PEPTIDES AND FORMULATIONS CONTAINING SAME
BR0014652A (en) Manufacture of therapeutic agent-polyglutamate conjugates
HK1069316A1 (en) Hmgb1 protein inhibitors and/or antagonists for the treatment of vascular diseases
DE60043305D1 (en) PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF INSULIN RESOURCE
DE60232660D1 (en) HUMAN DR4 ANTIBODIES AND ITS APPLICATIONS
CY1109361T1 (en) Substituted 4-Aminocyclohexanols
CY1113116T1 (en) Substituted 4-Aminocyclohexanols
HK1085386A1 (en) Pharmaceuticals comprising shikonins active constituent
CY1107231T1 (en) Substituted 4-Aminocyclohexanol derivatives
DE50212280D1 (en) USE OF HMGB PROTEINS AND NUCLEIC ACIDS COORDINATING THEREOF
WO2005087792A3 (en) Materials and methods relating to the treatment of glioblastomas
DE60016047D1 (en) DIHYDROBENZOPYRANE, DIHYDROBENZOTHIOPYRANE AND TETRAHYDROCHINOLINE FOR THE TREATMENT OF COX-2-DEPENDENT DISEASES
ATE405249T1 (en) BODY ODOR-CHANGING BIOLOGICALLY ACTIVE SUBSTANCES
DE602004007924D1 (en) THROMBOPOIETINE PROTEINS WITH IMPROVED PROPERTIES
ATE494307T1 (en) NEOPLASMA-SPECIFIC ANTIBODIES AND THEIR USES
DE50114335D1 (en) LH-RH ANTAGONISTS, THEIR PREPARATION AND THEIR USE AS DRUGS
NO20042476L (en) Use of desoxypeganine for the treatment of clinical depression
DE502006004735D1 (en) MEANS FOR THE TREATMENT OF INFECTIONS
DE60327249D1 (en) ANTHRANILIC ACID AMIDE AND ITS PHARMACEUTICAL USE
LT2002131A (en) New use of fir oil for cosmetic
BR0202759A (en) Modified release pharmaceutical composition containing bupropion as active substance
Critical Care Society of South Africa Working Group Severe sepsis and the role of novel therapeutic agents. Position statement of the Critical Care Society of South Africa on severe sepsis and the role of novel therapeutic agents such as drotrecogin alfa (activated)
FR2834897B1 (en) ORODISPERSIBLE PHARMACEUTICAL COMPOSITION OF TESTOSTERONE

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties